SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001367644-23-000157
Filing Date
2023-08-15
Accepted
2023-08-15 12:36:56
Documents
4
Period of Report
2023-08-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1692117406.html 3  
1 FORM 3 wk-form3_1692117406.xml 3 6603
2 EX-24.1 hartzelpoasigned.htm EX-24.1 902
3 hartzelpoasigned001.jpg GRAPHIC 211059
4 hartzelpoasigned002.jpg GRAPHIC 92620
  Complete submission text file 0001367644-23-000157.txt   427259
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 PROFESSIONAL DRIVE, STE. 400 GAITHERSBURG MD 20879
Business Address
Hartzel William (Reporting) CIK: 0001989644 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33137 | Film No.: 231174071